IRS Provides Insight Into Treatment of Transferable Incentives

This article originally appeared in Bloomberg Tax/Tax Management MemorandumTM

In an internal advice on the tax treatment of a pharmaceutical company’s incurred costs in purchasing from a third party a voucher to get expedited review of a new product, the IRS Chief Counsel’s Office provides insight into the treatment of transferable incentives generally.